Skip to main content

Un ibuprofeno al día podría impedir el desarrollo del Mal de Parkinson

Los científicos observaron que los usuarios habituales de ibuprofeno tenían un 40% menos de probabilidades de desarrollar Parkinson que las personas que no lo tomaban. Además, las personas que tomaban cantidades mayores de ibuprofeno tenían menos probabilidad que las que tomaban cantidades menores.


PERIODISMO.COM (WWW.NEOMUNDO.COM.AR, (FUENTE: SINC) JUEVES, 18 DE FEBRERO DE 2010 Una nueva investigación, publicada en la revista Neurology, muestra que las personas que toman ibuprofeno de manera periódica pueden reducir el riesgo de desarrollar la enfermedad de Parkinson. Los hallazgos del estudio se presentarán en el 62º Congreso Anual de la American Academy of Neurology.
"El ibuprofeno fue el único medicamento antiinflamatorio no esteroideo (AINE) vinculado a un menor riesgo de desarrollar párkinson", afirma Xiang Gao, uno de los autores del estudio e investigador en la Facultad de Salud Pública de Harvard (EE UU).
En la investigación, publicada en el último número de la revista Neurology, participaron 136.474 personas que no tenían la enfermedad de Parkinson. Se preguntó a los pacientes si utilizaban AINEs como la aspirina, el ibuprofeno y el acetaminofeno. Al cabo de seis años, 293 participantes desarrollaron la enfermedad.
Los científicos observaron que los usuarios habituales de ibuprofeno tenían un 40% menos de probabilidades de desarrollar Parkinson que las personas que no lo tomaban. Además, las personas que tomaban cantidades mayores de ibuprofeno tenían menos probabilidad que las que tomaban cantidades menores. Los resultados fueron los mismos independientemente de la edad, consumo de tabaco e ingesta de cafeína.
"Otros AINEs y analgésicos, incluida la aspirina y el acetaminofeno, no parecieron tener ningún efecto para reducir el riesgo de enfermedad, explica Gao. Es necesaria una mayor investigación para descubrir cómo y por qué el ibuprofeno parece reducir el riesgo de desarrollar párkinson, una patología que afecta a un millón de personas sólo en EE UU", concluye el experto.
http://www.diariosalud.net/index.php?option=com_content&task=view&id=18218&Itemid=413

Comments

Popular posts from this blog

Nordic Walking Benefits, ADHD and Diet, Supplements and Cancer, Sources of Fiber

A Better Way To Walk: Nordic Walking Improves Quality of Life, Depression, and Functional Capacity SciTechDaily Reference: “Sustained Effects of Different Exercise Modalities on Physical and Mental Health in Patients With Coronary Artery Disease: A Randomized ... Dietary Interventions for ADHD: Emerging Research and Considerations There has been increasing interest in the role that diet and supplements play in the treatment of attention-deficit/hyperactivity disorder (ADHD) symptoms, from patients and researchers alike. Diet is an important treatment approach to consider, as it is a lifestyle change rather than a medication. Additionally, at least 10% to 30% of children with ADHD are non-responsive to, or experience adverse effects from, ADHD medications­­­­.1 A dietary approach to ADHD can be complementary to a conventional pharmacological approach, giving patients and their families more options toward a personalized treatment plan. This article will examine current research about di

More People Are Microdosing for Mental Health. But Does It Work?

By Dana G Smith. Joseph started microdosing psychedelics five years ago to try to improve his mental health. “I was just kind of in this depression, in this rut,” he said. “I was unhappy and angry and agitated all the time, and it went against the way that I saw myself.” Depression and anxiety run in Joseph’s family, and he’d been prescribed Prozac as a kid. But when symptoms of depression returned in his early 30s, he didn’t want to go back to a prescription drug. Joseph, an Austin-based designer (he asked to withhold his full name, citing privacy concerns surrounding mental health issues and illegal drug use), came across research from Johns Hopkins University about psilocybin, the active ingredient in hallucinogenic, or “magic,” mushrooms. In a small study, full doses of the drug helped cancer patients cope with depression and anxiety. Then he read anecdotes of Silicon Valley influencers claiming increased energy from taking tiny doses of psychedelics. So he decided to start microdo

Exploring the Link Between Circadian Rhythms, Longevity, and Wearable Data: Insights and Future Directions

A recent study in NHANES 2011–2014 explores the potential connection between disruptions in circadian rhythms, measured using wearable devices, and their impact on health outcomes and longevity. The study analyzes data from 7,297 U.S. adults collected through wearable accelerometers as a novel digital biomarker for longevity. Five distinct clusters were identified based on activity profiles: "High activity," "Low activity," "Mild circadian rhythm (CR) disruption," "Severe CR disruption," and "Very low activity." The findings reveal that young adults with extreme circadian rhythm disturbance exhibit higher white blood cell counts and accelerated biological aging. Older adults with circadian disruption are associated with increased systemic inflammation indexes, advanced biological aging, and higher all-cause mortality risk. The research underscores the importance of circadian alignment for longevity at all ages and suggests that wearable